Uterine Manipulation Devices Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application (Total Laparoscopy Hysterectomy, Laparoscopic Supracervical Hysterectomy, Laparoscopically Assisted Vaginal Hysterectomy, Sacrocolpopexy, others), By End-use (Hospitals & Clinics, Ambulatory Surgical Centers, others), by Region, and Competition, 2020-2030F

Market Overview

The Global Uterine Manipulation Devices Market, valued at USD 282.56 Million in 2024, is projected to experience a CAGR of 6.27% to reach USD 406.87 Million by 2030. Uterine manipulation devices are specialized surgical instruments designed to provide optimal control and mobility of the uterus during various gynecological procedures, primarily in minimally invasive settings. These devices, typically inserted via the cervix, enable surgeons to precisely position the uterus for improved visualization and access to pelvic structures during operations such as laparoscopic hysterectomies and myomectomies. The market's expansion is significantly driven by the increasing global preference for minimally invasive surgeries due to benefits like reduced patient recovery times, the rising prevalence of gynecological conditions, and ongoing technological advancements enhancing device precision and ergonomics. For example, according to the American Cancer Society, in January 2024, approximately 67,880 new cases of uterine cancer are expected in the U. S. in 2024, necessitating surgical interventions. Further impetus comes from growing demand for fertility treatments.

However, a significant challenge impeding market growth is the high cost associated with advanced uterine manipulation devices. These expenses can be prohibitive for numerous healthcare facilities, particularly in developing regions, thereby limiting broader market penetration and adoption.

Key Market Drivers

The increasing adoption of minimally invasive gynecological surgeries is a primary driver for the Global Uterine Manipulation Devices Market. These procedures are highly valued for their reduced patient trauma, shorter recovery times, and lower complication rates compared to traditional open surgeries. Uterine manipulation devices are essential in these settings, enabling surgeons with enhanced control and visualization for operations like laparoscopic hysterectomies and myomectomies. According to Medscape, in April 2023, robotic-assisted laparoscopic hysterectomy constituted 65.8% of total hysterectomy surgeries, reflecting a significant procedural shift towards advanced minimally invasive techniques. Concurrently, the rising prevalence of gynecological disorders necessitates effective surgical interventions, thereby expanding the patient population requiring these specialized devices. Conditions such as endometriosis and uterine fibroids frequently require surgical correction, with minimally invasive approaches increasingly becoming the standard of care. According to the World Health Organization, in March 2023, endometriosis affects approximately 10% or 190 million reproductive-age women and girls globally, underscoring the persistent demand for precise uterine positioning tools during these procedures.

This combined impact of evolving surgical preferences and increasing disease burden fundamentally drives market growth. Continued technological advancements and integration with robotically assisted surgical systems further enhance device capabilities, improving surgical outcomes across gynecological interventions. The widespread utilization of such advanced platforms exemplifies this progression. According to the American Hospital Association (AHA), as of 2024, the da Vinci robotic surgical system facilitated approximately 2.68 million procedures globally, demonstrating the extensive operational reliance on sophisticated instrumentation within contemporary gynecology.

Download Free Sample Report

Key Market Challenges

The primary impediment to the expansion of the Global Uterine Manipulation Devices Market is the substantial cost associated with these advanced surgical instruments. These high expenses present a significant financial barrier for numerous healthcare facilities, particularly in developing regions, where budget allocations for medical equipment are frequently constrained. This directly limits the acquisition and widespread adoption of these devices, despite the recognized benefits of minimally invasive gynecological procedures they enable.

For instance, according to the International Federation of Hospital Engineering, in 2023, nearly 55% of hospitals in low and middle-income countries identified limited capital budgets as a critical obstacle to procuring modern medical technology. This financial constraint curtails the market's penetration into underserved areas and restricts the ability of a broader range of hospitals to integrate advanced uterine manipulation devices into their surgical practices, thereby directly impeding overall market growth.

Key Market Trends

The integration of digital and AI-powered surgical platforms is a significant trend transforming the Global Uterine Manipulation Devices Market by enhancing procedural precision and efficiency. These advanced systems provide surgeons with data-driven insights, real-time guidance, and optimized workflows, improving decision-making during complex gynecological procedures. According to MedTech Europe, the European medical technology market was estimated to be roughly €170 billion in 2024, reflecting a substantial base for digital innovation within the healthcare sector. This progression is further exemplified by companies like Medtronic, which introduced new AI algorithms for post-operative analysis in laparoscopic and robotic-assisted surgery in April 2024, offering enhanced surgical insights and training opportunities.

Another key trend is the growing preference for disposable uterine manipulators, driven primarily by escalating concerns over infection control and the pursuit of operational efficiency. Disposable devices guarantee sterility for each procedure, mitigating the risks of cross-contamination and eliminating the substantial costs and logistical complexities associated with reprocessing reusable instruments. According to a 2023 survey highlighted by the Association for Healthcare Resource & Materials Management (AHRMM), 78% of healthcare purchasing leaders prioritized cost efficiency, which directly influences the adoption of single-use items to streamline supply chain processes. Moreover, an observational study published in the American Journal of Obstetrics and Gynecology in August 2024 revealed that excess use of disposable materials and equipment is common in minimally invasive benign gynecologic surgeries, with robotic surgery contributing 52.19% of the total excess cost, emphasizing the prevalent use and cost implications of disposables.

Segmental Insights

The Total Laparoscopy Hysterectomy (TLH) segment is experiencing rapid growth in the Global Uterine Manipulation Devices Market, driven by its inherent advantages as a minimally invasive surgical approach. This method involves smaller incisions, leading to significantly reduced tissue trauma, less postoperative pain, and quicker patient recovery compared to traditional open procedures. Furthermore, TLH offers surgeons enhanced visualization and precision through magnified views of the surgical site, which contributes to improved surgical outcomes and reduced complication rates. The increasing prevalence of various gynecological conditions requiring hysterectomy, coupled with a rising patient and physician preference for less invasive interventions, further propels the demand for uterine manipulation devices specifically designed for TLH procedures.

Regional Insights

North America leads the global uterine manipulation devices market, primarily driven by its advanced healthcare infrastructure and substantial investments in research and development. The region's dominance is further solidified by the high adoption rate of minimally invasive surgical procedures and innovative medical technologies, alongside a significant patient population requiring gynecological treatments. Stringent regulatory standards, such as those upheld by the U. S. Food and Drug Administration, ensure product quality and safety, fostering market trust and growth. Additionally, favorable reimbursement policies and the strong presence of key market players contribute significantly to North America's leading position in this sector.

Recent Developments

• In October 2025, Medtronic plc initiated the Embrace Gynecology investigational device exemption (IDE) U.S. clinical study. This study is designed to evaluate the safety and effectiveness of its Hugo™ robotic-assisted surgery (RAS) system for robotic-assisted gynecological procedures, including total hysterectomies. The initial procedures were successfully completed at AHN West Penn Hospital in Pittsburgh. This clinical research aims to expand minimally invasive treatment options, indicating a continuous advancement in surgical technology that complements and integrates with uterine manipulation techniques within the global market.

• In July 2025, Progressive Medical, Inc. (PMI) announced that its SOLOBAG™ had joined its Specimen Retrieval Portfolio. This addition supports various laparoscopic surgical procedures where efficient and safe specimen removal is critical. While not a uterine manipulation device itself, the SOLOBAG™ is integral to the broader suite of tools used in minimally invasive gynecological surgeries that frequently employ uterine manipulators. The introduction of such products demonstrates ongoing advancements in ancillary devices that enhance the safety and workflow of procedures within the global uterine manipulation devices market.

• In November 2024, Olympus Corporation showcased its extensive range of gynecological solutions at the American Association of Gynecological Laparoscopists (AAGL) World Congress. Among the highlighted innovations was its contained tissue extraction system, specifically designed for laparoscopic hysterectomy and myomectomy. This system integrates the PneumoLiner™ containment device with a next-generation laparoscopic PK Morcellator, allowing surgeons to utilize minimally invasive approaches for tissue removal. This development underscores the company's commitment to enhancing safety and precision in gynecological surgeries, directly impacting the utility and design considerations for uterine manipulation devices.

• In August 2024, CooperCompanies announced that its subsidiary, CooperSurgical, acquired obp Surgical. This acquisition expanded CooperSurgical's portfolio of leading medical devices by incorporating obp Surgical's suite of single-use cordless surgical retractors, which feature integrated LED light sources and smoke evacuation channels, as well as single-use surgical suction devices. This strategic move strengthens CooperSurgical's offerings in the surgical space, providing clinicians with a broader range of innovative tools utilized in gynecological procedures where uterine manipulation devices are essential for access and visualization.

Key Market Players

• Conkin Surgical Instrument Ltd.
• Johnson & Johnson Services, Inc.
• CooperSurgical, Inc.
• B. Braun SE
• KARL STORZ GmbH & Co. KG
• CONMED Corporation
• RUDOLF Medical GmbH + Co. KG
• LiNA Medical ApS
• Richard Wolf GmbH
• Utah Medical Products, Inc.

Report Scope:

In this report, the Global Uterine Manipulation Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Uterine Manipulation Devices Market, By Application:

o   Total Laparoscopy Hysterectomy

o   Laparoscopic Supracervical Hysterectomy

o   Laparoscopically Assisted Vaginal Hysterectomy

o   Sacrocolpopexy

o   Others

• Uterine Manipulation Devices Market, By End User:

o   Hospitals & Clinics

o   Ambulatory Surgical Centers

o   Others

• Uterine Manipulation Devices Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Uterine Manipulation Devices Market.

Available Customizations:

Global Uterine Manipulation Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Uterine Manipulation Devices Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]